Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effect of hyperdynamic therapy on cerebral ischaemia caused by vasospasm associated with subarachnoid haemorrhage


Ten patients who developed neurological deficits associated with angiographically proven cerebral vasospasm caused by ruptured aneurysm were treated with hyperdynamic therapy induced by administration of a large amount of human serum albumin. No vaso-active drugs were administered. Cardiopulmonary function and intracranial pressure were monitored during the treatment. Marked improvement of neurological function was observed in all cases. Nine patients recovered completely without any neurological residual following treatment. The degree of the improvement observed during treatment closely correlated with the decrease in total peripheral resistance. Infusion of albumin did not cause elevation of intracranial pressure. It was concluded that the hyperdynamic therapy induced by administration of albumin has a dramatic effect on the ischaemic cerebral insult caused by vasospasm. It is postulated that the main effect of this treatment is produced by cerebrovascular dilatation.

This is a preview of subscription content, log in to check access.


  1. 1.

    Fein, J. M., Boulos, R., Local cerebral blood flow in experimental middle cerebral artery vasospasm. J. Neurosurg.39 (1973), 337–347.

  2. 2.

    Kindt, G. W., McGillicuddy, J. E., Giannotta, S. L., Pritz, M. B., The reversal of neurologic deficit in patients with acute cerebral ischaemia by profound increases in intravascular volume. In: Cerebral Blood Flow and Metabolism (Gotoh, F., Nagai, H., Tazaki, Y., eds.). Copenhagen: Munksgaard. 1979.

  3. 3.

    Kindt, G. W., McGillicuddy, J. E., Pritz, M. B., Giannotta, S. L., Hypertension and hypervolemia as therapy for patients with vasospasm. In: Cerebral Arterial Spasm (Wilkins, R. H., ed.), pp. 659–664. Baltimore-London: Williams and Wilkins. 1980.

  4. 4.

    Kosnic, E. J., Hunt, W. E., Postoperative hypertension in the management of patients with intracranial arterial aneurysm. J. Neurosurg.45 (1976), 148–154.

  5. 5.

    Millikan, C. H.,et al., A classification and outline of cerebrovascular diseases II. Stroke6 (1975), 565–616.

  6. 6.

    Symon, L.,et al., The use of the Xenon clearance method in subarachnoid hemorrhage. Eur. Neurol.8 (1972), 8–14.

  7. 7.

    Takagi, H., Yada, K., Ohwada, T., Saitoh, T., An analysis of postoperative time course of ICP in 35 cases with intracranial aneurysms. In: Intracranial Pressure III (Beks, J. W. F., Bosch, D. A., Brock, M., eds.), pp. 152–156.Berlin-Heidelberg-New York: Springer. 1976.

  8. 8.

    Tanabe, T., Morii, S., Miyasaka, Y., Saitoh, T., Yada, K., Significance of cardiac output in treatment of cerebral vasospasm. In : Fifth Asian-Australasian Congress of Neurological Surgery (Gustilo, R. H., ed.), p. 63. Manila, Philippines, 1979.

  9. 9.

    Yada, K., Abe, H., Tsuru, M., Intracranial pressure following intracranial surgery. Brain and Nerve19 (1967), 565–571.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tanabe, T., Saitoh, T., Tachibana, S. et al. Effect of hyperdynamic therapy on cerebral ischaemia caused by vasospasm associated with subarachnoid haemorrhage. Acta neurochir 63, 291–296 (1982).

Download citation


  • Albumin
  • Serum Albumin
  • Human Serum
  • Interventional Radiology
  • Human Serum Albumin